Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Plinabulin vs Pegfilgrastim for Chemotherapy-Induced Neutropenia (Protective-1)
NCT03102606Phase 3Completed
- Sponsor
- BeyondSpring Inc.
- Start
- May 2018
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 3 trial of plinabulin in chemotherapy-induced neutropenia (CIN), sponsored by BeyondSpring Inc.. Started May 2018; status: completed.
02
Drugs
plinabulin
03
Conditions
chemotherapy-induced neutropenia (CIN)
Beyond the preview
Go deeper on NCT03102606.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03102606.